ArticlePharmaceutical biology2022

Stachydrine is effective and selective against blast phase chronic myeloid leukaemia through inhibition of multiple receptor tyrosine kinases.

Ruixin Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.